Immunogenicity of COVID-19 mRNA vaccines in hemodialysis patients: Systematic review and meta-analysis.

Shahab FalahiHojjat SayyadiAzra Kenarkoohi

Published in: Health science reports (2022)

Although the immune response of hemodialysis patients to the second dose of the SARS-CoV-2 mRNA vaccine is very promising, the seroconversion rate of dialysis patients is lower than healthy controls. Periodically assessment of antibody levels of hemodialysis patients at short intervals is recommended.

Keyphrases

end stage renal disease
sars cov
chronic kidney disease
peritoneal dialysis
immune response
ejection fraction
coronavirus disease
newly diagnosed
respiratory syndrome coronavirus
binding protein
inflammatory response